Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Silencing of immune activation with methotrexate in patients with COVID-19

25 May 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Long-Term Effects of COVID-19
Share to SARS-CoV-2 and COVID-19 Research

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 32471659
DOI: 10.1016/j.jns.2020.116942

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Silencing of immune activation with methotrexate in patients with COVID-19PMID 32471659Read ↗

T-cell dysregulation in COVID-19Semantic proximity Read ↗

Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?Semantic proximity Read ↗

COVID-19 disease and immune dysregulationSemantic proximity Read ↗

Immune response in COVID-19: What do we currently know?Semantic proximity Read ↗

Myeloid-derived suppressor cells in COVID-19: A reviewSemantic proximity Read ↗

Long COVID immune phenotypes identified for blockade.Semantic proximity Read ↗

Cytokine release syndrome in severe COVID-19Semantic proximity Read ↗

Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activationSemantic proximity Read ↗

Analysis and identification of potential type II helper T cell (Th2)-Related key genes and therapeutic agents for COVID-19Semantic proximity Read ↗

COVID-19 in patients with rheumatological diseases treated with anti-TNFSemantic proximity Read ↗

The type I interferon response in COVID-19: implications for treatmentSemantic proximity Read ↗

Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responsesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.